T Cells That Clean Zombie Cells: An Israeli Breakthrough in Aging

Once in a while, a study is published that moves the entire field of aging forward, and this time it came from the Negev. A team of researchers from Ben-Gurion University, in collaboration with the Weizmann Institute of Science, published a finding in Nature Aging that changes the way we understand aging: the body already has an internal mechanism that cleans the senescent cells that accumulate with age, but this mechanism weakens precisely when we need it most.

For years, the field of aging focused on external drugs to eliminate zombie cells, those senescent cells that stop dividing but refuse to die and poison the surrounding tissues. The big surprise in the Israeli study: it turned out that the immune system already has an entire subpopulation of cells dedicated to this exact task. These are T cells that clean zombie cells, a special type of CD4 helper cells that have acquired killing ability.

The main achievement: the researchers identified these cells and proved in mice that they are essential for longevity. To link the finding to humans, they relied on a separate Japanese study from 2019 that found exactly these same cells in exceptional abundance in supercentenarians, people living over the age of 110. In other words, one of the secrets of exceptional longevity may be this internal cleaning force, not just good genes or luck.

What are zombie cells and why are they harmful?

To understand why the finding is so significant, one must know the senescent cells, or by their common name, zombie cells. These are cells that have accumulated damage, stopped dividing, but have not undergone programmed cell death. They remain in the tissue like tenants who don't pay rent but refuse to vacate the apartment.

• They accumulate with age: In youth, the immune system clears them quickly, but over the years the clearance rate decreases and they multiply.
• They secrete inflammatory toxins: These cells release a load of inflammatory substances called SASP (Senescence-Associated Secretory Phenotype), which damages the healthy cells around them.
• They drive age-related diseases: The accumulation of zombie cells is linked to atherosclerosis, arthritis, diabetes, muscle wasting, and neurodegenerative diseases.
• They are a cause, not just a result: In mice, intentional removal of zombie cells extended lifespan and improved function in many organs, making them a central target in aging science.

The problem is that the accumulation of zombie cells is not just a sign of aging, but an active driver of it. As they multiply, chronic inflammation in tissues increases, and this is the inflammation known as inflammaging.

The connection to the immune system: the surprising mechanism

Here enters the novelty of the Israeli study. For years, we thought of CD4 immune cells, the helper cells, mainly as coordinators: they give orders to other immune cells but do not kill themselves. Killing was considered the task of CD8 cells, the classic cytotoxic cells.

The researchers discovered that with age, a special subpopulation of CD4 cells develops that acquires killing ability. They are marked by a control protein called Eomesodermin, or Eomes for short, and express a signaling molecule called CCL5. Because of this marker, they are called CD4-Eomes cells. In effect, these are helper cells that have been retrained for the role of professional killers specializing in eliminating senescent cells.

The mechanism is elegant: the more zombie cells accumulate in the tissue, the more CD4-Eomes cells multiply to deal with them. The researchers showed that this is a response to an environment rich in senescent cells, and when the zombie cell load was reduced, the conversion of CD4 cells also stopped. This is a natural feedback system: wear and tear summons the cleaning force.

But there is a catch. With aging, the ratio reverses. The rate of zombie cell creation exceeds the rate of their clearance, and the internal cleaning force loses the battle. The result is accumulation, inflammation, and accelerated aging. Understanding this mechanism opens up a completely new possibility: instead of only killing zombie cells with a drug, one could strengthen the body's natural police force.

The current evidence

Study 1: Identification of the cells and their molecular mapping

The team, led by Prof. Alon Monsonego and Dr. Yehezkel Elyahu from Ben-Gurion University, mapped immune cell populations throughout life and identified for the first time a rare subpopulation of CD4-Eomes cells as a distinct group with a unique genetic signature of killing and the CCL5 molecule. They showed that these cells multiply with age, meaning they are not a defect of aging but a late protective response.

Study 2: The removal experiment in mice, the causal proof

This is the most dramatic finding. The researchers intentionally removed CD4-Eomes cells from aged mice and observed the result. The mice from which the cells were removed accumulated more zombie cells, suffered accelerated physical decline, and lived shorter lives. This is not just a correlation, but causal proof: these cells are not a byproduct of healthy aging, they are an essential factor in it. Without them, aging is accelerated.

Study 3: Supercentenarians over age 110, the human evidence

To bridge to humans, the team relied on a previous finding from a separate Japanese study published in 2019 on supercentenarians, people living over the age of 110. That study found that their immune system is rich in exactly the same subpopulation of cytotoxic T cells. The correspondence between the Israeli finding in mice and the Japanese human data is a strong hint that these cells are relevant to exceptional human longevity, not just a lab model.

Collaboration with the Weizmann Institute

The study was done in collaboration with Prof. Valery Krizhanovsky from the Weizmann Institute of Science, one of the world's leading names in the study of senescent cells and the development of strategies for their removal. The combination of expertise in immune system research from Ben-Gurion with senescence research from Weizmann is what allowed the connection between the two fields. This is an Israeli research network with a presence at the global forefront of the field.

What about the brain and other organs?

Beyond this specific study, it is worth noting a broader context: Prof. Monsonego has been researching brain aging and neurodegenerative diseases for years. In the general literature, it is known that zombie cells also accumulate in the aging brain and contribute to neuroinflammation linked to Alzheimer's and Parkinson's, although the current study itself did not examine the brain aspect.

If an effective immune cleaning force can curb the zombie cell load, the implications may extend far beyond general longevity, towards preserving cognitive function. The same principle applies to every organ where senescent cells accumulate: from the heart and kidneys to the muscles and skin. A balanced immune system is a maintenance system for the entire body.

Should we rush to strengthen the immune system?

Here caution is required. Despite the excitement, there is a large gap between the lab and human treatment, and several important warnings:

• Most evidence is in mice. The causal proof, that removing the cells shortens lifespan, was done in mice. Human data is based on a correlation in long-lived individuals, not a clinical trial.
• Balance, not blind enhancement. As the researchers emphasized, the goal is not a "super-strong" immune system. An overactive immune system can attack healthy tissues and cause autoimmune diseases or harmful inflammation. The secret is a balanced system, appropriate for age.
• There is no drug yet. There is currently no approved way to specifically increase CD4-Eomes cells in humans. The path to developing a safe treatment is still long.
• Beware of marketing promises. No "immune-boosting" supplement sold today targets this specific subpopulation, and there is no evidence it affects it.

In short: this is a real scientific breakthrough that opens a new therapeutic direction, but it is not an invitation for immediate action at home.

What can be taken from the study?

Even without a dedicated drug, one can support immune system health and reduce zombie cell load through known mechanisms:

1. Regular physical activity. Aerobic and strength training reduce inflammatory load, support T cell function, and help the body clear damaged cells more efficiently.
2. Reducing chronic inflammation. Visceral obesity, smoking, poor sleep, and gum disease accelerate zombie cell accumulation and inflammaging. Any step that reduces inflammation supports the natural cleaning force.
3. A Mediterranean diet rich in plants. An eating pattern rich in vegetables, fruits, legumes, and olive oil is associated with lower inflammation levels and better immune health throughout age.
4. Moderate intermittent fasting. Moderate energy restriction activates cellular cleaning mechanisms like autophagy, which contribute to tissue quality and immune function.
5. Follow senolytic research. In older age groups, clinical trials are currently underway for compounds that clear zombie cells, such as fisetin and the combination of dasatinib with quercetin. Consult a doctor before any self-experimentation; these are not harmless supplements.

The broader perspective

This study is part of a deep conceptual revolution in aging research. For decades, we perceived the immune system mainly as a defense system against bacteria and viruses. The finding from Ben-Gurion and Weizmann joins a growing wave of evidence that the immune system is also the body's central maintenance system, responsible for identifying and eliminating damaged cells that accelerate aging.

And there is also an Israeli pride story here. While American tech giants pour billions into longevity research, two Israeli academic labs, in the Negev and Rehovot, laid an important cornerstone in understanding the connection between immunity and aging, and did so at the global forefront of the field. This is a reminder that Israeli science is at the center of the aging race.

Still, the bottom line is cautious science: what was proven in mice and hinted at in long-lived individuals will need years of research to become a treatment. But for the first time, we have proof that the body itself holds a powerful tool against aging, and perhaps the key is not to invent something new, but to restore to our internal cleaning force the power it had in youth.

References:
The Times of Israel: Medical Holy Grail, Israeli researchers isolate elusive cells that may slow down aging
Nature Aging: CD4 T cells acquire Eomesodermin to modulate cellular senescence and aging (Elyahu, Monsonego, Krizhanovsky et al., Ben-Gurion University and Weizmann Institute, 2025)